Skip to content
Review Open access

Palmitoylation reprograms the intestinal mucosal barrier microenvironment: potential mechanisms and promising therapeutic targets

Sep 2026 · Frontiers in Pharmacology · Vol 17 · 0 citations · 93 references
Medicine

TL;DR

This review systematically proposes a conceptual framework for the “reprogramming of the intestinal mucosal barrier microenvironment by S-palmitoylation” to provide novel molecular targets and a theoretical foundation for the development of mucosal healing therapies that are independent of traditional immunosuppression.

Abstract

Homeostasis of the intestinal mucosal barrier microenvironment is contingent upon the coordinated interplay among mechanical, chemical, and immunological barriers. Recent studies have demonstrated that protein S-palmitoylation, a dynamic and reversible lipid modification, holistically reprograms the intestinal mucosal barrier microenvironment. This is achieved by modulating the membrane localization of tight junction proteins (Claudins and ZO proteins) and E-cadherin/catenin complexes, the secretion and anchoring of MUC2, as well as the membrane recruitment and signaling activation of receptors such as TLR4, NOD2, and NLRP3. Dysregulation of this modification not only drives barrier collapse and chronic inflammation in inflammatory bowel diseases (IBD), such as ulcerative colitis, but also exacerbates pathological progression by modulating the phenotypic remodeling of innate immune cells, including macrophages and neutrophils. Targeting the palmitoylation cycle—including ZDHHC acyltransferases, depalmitoylases (APTs and PPTs), or upstream metabolic enzymes like FASN—using either the broad-spectrum inhibitor 2-BP or selective inhibitors (ML348 and Palmostatin B), has shown promise in preclinical models restore barrier function and attenuate intestinal inflammation. However, it is important to emphasize that the therapeutic potential of these agents in IBD is currently supported primarily by in vitro and animal studies, and their clinical efficacy and safety remain to be established. This review systematically proposes a conceptual framework for the “reprogramming of the intestinal mucosal barrier microenvironment by S-palmitoylation.” By integrating current evidence spanning from molecular modifications to barrier functions and from mechanistic insights to therapeutic strategies, we aim to provide novel molecular targets and a theoretical foundation for the development of mucosal healing therapies that are independent of traditional immunosuppression.

Read PDF

Similar papers

Open access Sep 2026

Palmitoylethanolamide as an Intestinal Gatekeeper: Linking Inflammation, Angiogenesis and Colorectal Cancer Interception

Angiogenesis is a major determinant of tumor growth, progression and metastatic potential, and its persistent activation is closely intertwined with chronic inflammation. This relationship is particularly relevant in malignancies that arise through a prolonged inflammation-to-carcinogenesis continuum, where pathologica...

Irene Palenca, G. Sarnelli, Giuseppe Esposito · 0 citations
Open access Oct 2026

NK2R signaling governs intestinal lipid mobilization and mucosal inflammation

Findings position NK2R as a molecular switch for intestinal lipid handling and mucosal inflammation and suggest that NK2R-targeted agonists or antagonists could be deployed as context- and sex-dependent therapeutic strategies for metabolic disease and inflammatory bowel disease.

P. A. Perez, Chung-Chih Liu, Alessandra Ferrari et al. · 0 citations
Open access Sep 2026

HMGCS2-mediated ketogenesis maintains intestinal barrier in inflammatory bowel disease by inhibiting ferroptosis

Complete mucosal healing is a key therapeutic goal in inflammatory bowel disease (IBD). While ferroptosis-mediated epithelial cell death is known to compromise the mucosal barrier as the cornerstone of mucosal healing, the precise mechanisms driving this process during IBD pathogenesis remain to be fully elucidated...

Jing Han, Xiao-Ling Li, Ying Wang et al. · 0 citations
Review Open access Sep 2026

Context-dependent roles of resistin-like molecule β in mucosal defense and inflammatory diseases

A compartment–interaction system framework is proposed that considers protein source, route of exposure, molecular assembly, local physicochemical conditions, and available interaction partners as potential determinants of biological outcome and is presented as a testable synthesis for defining experimental priorities...

Qi Ai, Wen Chen, Wen Chen et al. · 0 citations
Review Open access Oct 2026

Intestinal permeability and the zonulin pathway: tight junctions, mucosal immunity, dietary modulators and clinical relevance

The intestinal barrier separates the luminal content, including the gut microbiota, dietary antigens and toxins, from the mucosal immune system, and its integrity is essential for immune homeostasis. Loss of barrier control, commonly termed increased intestinal permeability or leaky gut, has been implicated in a broad...

David Granizo-Bermejo, Guillermo García-Pérez-de-Sevilla, Antonio Molina-López · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.